Effectiveness of storage as a point-of-use means of improving the bacteriological quality of drinking water

The evaluation of the effectiveness of storage as a point-of-use means for improving the bacteriological quality of drinking water was carried out using a completely randomized block design. Total plate and total coliform counts were enumerated for day 0 -10 samples using Nutrient Agar (NA) and multiple tube techniques respectively. Physicochemical analyses of water samples were carried out using standard procedures including titrimetric methods. Ten bacteria species including Escherichia coli, Bacillus cereus, Citrobacter freundil, Salmonella typhymurium, Pseudomonas aeruginosa, Staphylococcus aureus, Klebsiella pneumoniae, Arizona spp., Proteus vulgaris, Enterobacter aerogenes were isolated from water samples obtained from borehole, well and sachet water samples in the study area. For day zero samples, it was found that the total bacteria counts ranged from 1.01x102 to 4.38 x102 CFU/mL for borehole, 0.57x102 to 2.13x102 CFU/mL for well and 0.54x102 to 0.92x102 CFU/mL for sachet water. A significant reduction in bacteria load was recorded for all samples from day 2 to day 7 when the water samples were monitored over a period of ten days. The results reveal that water storage for 2-7 days is a viable point-of-use method of household level drinking water disinfection. © 2013 International Formulae Group. All rights reserved.Keywords: Nigerian Institute of Standards, Coliforms, water storage, E.coli

Delivery of oligonucleotides with lipid nanoparticles

Since their inception in the 1980's, oligonucleotide-based (ON-based) therapeutics have been recognized as powerful tools that can treat a broad spectrum of diseases. The discoveries of novel regulatory methods of gene expression with diverse mechanisms of action are still driving the development of novel ON-based therapeutics. Difficulties in the delivery of this class of therapeutics hinder their in vivo applications, which forces drug delivery systems to be a prerequisite for clinical translation. This review discusses the strategy of using lipid nanoparticles as carriers to deliver therapeutic ONs to target cells in vitro and in vivo. A discourse on how chemical and physical properties of the lipid materials could be utilized during formulation and the resulting effects on delivery efficiency constitutes the major part of this review